To dissect the question of whether SKA1 and SAFB play a clinical role and are implicated in the prognosis of renal carcinoma, aberrant expression of both genes was analyzed in the publicly available TCGA dataset consisting of 200 ccRCC patients with available follow-up data. This evidence concerns the gene SAFB and nonpapillary renal cell carcinoma.